12 January 2021 - Late treatment study
Treatment of COVID-19 patients with hydroxychloroquine or chloroquine: A retrospective analysis
et al., Research Square, doi:10.21203/rs.3.rs-119202/v1 (Preprint)
Small retrospective database analysis of 37 late stage patients hospitalized in an intensive care center in China, not finding a significant difference in viral shedding. Pateints were all in serious condition. There was only one death however the group is not specified. Confounding by indication is likely.
|
time to viral-, 40.0% higher, relative time 1.40, p = 0.06, treatment 18, control 19.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. |
Li et al., 1/12/2021, retrospective, database analysis, China, Asia, preprint, 5 authors.
Please send us
corrections, updates, or comments. Vaccines and treatments are both
valuable and complementary. All practical, effective, and safe means
should be used. Elimination of COVID-19 is a race against viral evolution. No
treatment, vaccine, or intervention is 100% available and effective for all
current and future variants. Denying the efficacy of any method increases
mortality, morbidity, collateral damage, and the risk of endemic status. We do
not provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. WCH
and FLCCC provide
treatment protocols.